Estudo comparativo duplamente encoberto entre Sevoflurano Genérico e Sevorane®
A double-blind comparative study between generic Sevoflurane and SevoraneTM
Alfredo Augusto Vieira Portella; Solange Maria Laurencel; Deise Martins Rosa; Maria Isabel Moscote Rivera; Santiago Osorno Quintero
Resumo
Palavras-chave
Abstract
Keywords
References
Baker MT. Sevoflurane: are there differences in products?. Anesth Analg. 2007;104:1447-1451.
Kharasch ED. Sevoflurane: the challenges of safe formulation. APSF Newsletter. 2007;48.
O'Neill B, Hafiz MA, DeBeer DAH. Corrosion of Penlon sevoflurane vaporisers. Anaesthesia. 2007;62.
Kharasch ED, Subbarao GN, Stephens DA. Influence of sevoflurane formulation water conten on degradation to hydrogen fluoride in vaporizers. Anesthesiology. 2007;107.
Stephens DA, Kharasch ED, Cromack KR. Sevoflurane vaporizers contain Lewis acid metal oxides that can potentially degrade sevoflurane. Anesthesiology. 2007;107.
Cromack KR, Kharasch ED, Stephens DA. Influence of formulation water content on sevoflurane degradation in vitro by Lewis acids. Anesthesiology. 2007;107.
Grupa A, Ely J. Faulty sevoflurane vaporizer. Anesthesia. 2007;62.
Rosner B. Fundamentals of Biostatistics. 1986.
Timm NH. Multivariate Analysis with Applications in Educations and Psychology. 1975.
Malviya S, Lerman J. The blood/gas solubilities of sevoflurane, isoflurane, halothane and serum constituent concentrations in neonates and adults. Anesthesiology. 1990;72:793-796.
Yasuda N, Targ AG, Eger EI. II - Solubility of I-653, sevoflurane, isoflurane and halothane in human tissues. Anesth Analg. 1989;69:370-373.
Katoh T, Suguro Y, Nakajima R. Blood concentrations of sevoflurane and isoflurane on recovery from anesthesia. Br J Anaesth. 1992;69:259-262.